Metraipolis › archive › dc_5ccecc834beb

The Use of JAK Inhibitors in Elderly Patients with Moderate-to-Severe Atopic Dermatitis: A Narrative Review of Clinical and Real-World Evidence — Europe PMC PMID:40944086

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40944086
DOI
10.3390/jcm14176327
License (as archived)
solo-consultazione
Archived
2026-11-10T02:07:32.060Z
SHA-256 of the archived text
00d2adaeddde741645134a9cd011031d63b5efb7559b2714d421d6a1384656a3
Stable URL of this page
https://metraipolis.com/documento/dc_5ccecc834beb

How to cite

The Use of JAK Inhibitors in Elderly Patients with Moderate-to-Severe Atopic Dermatitis: A Narrative Review of Clinical and Real-World Evidence — Europe PMC PMID:40944086 — Europe PMC (en), https://europepmc.org/article/MED/40944086 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ccecc834beb (Metraipolis archive dc_5ccecc834beb, sha256 00d2adaeddde741645134a9cd011031d63b5efb7559b2714d421d6a1384656a3)
BibTeX
@misc{dc5ccecc834beb,
  title = {The Use of JAK Inhibitors in Elderly Patients with Moderate-to-Severe Atopic Dermatitis: A Narrative Review of Clinical and Real-World Evidence — Europe PMC PMID:40944086},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40944086},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ccecc834beb; sha256 00d2adaeddde741645134a9cd011031d63b5efb7559b2714d421d6a1384656a3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40944086. Agents can read the archived copy with the MCP tool read_document.